SU5416 in Treating Children With Recurrent or Progressive Brain Tumors

NCT00006247 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

33

Enrollment

NETWORK

Sponsor class

Stopped The pharmaceutical company discontinued further development of SU5416.

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: semaxanib

Sponsor

Pediatric Brain Tumor Consortium

Collaborators

[object Object]